Evolution of parasite virulence when host responses cause disease.
The trade-off hypothesis of virulence evolution rests on the assumption that infection-induced mortality is a consequence of host exploitation by parasites. This hypothesis lies at the heart of many empirical and theoretical studies of virulence evolution, despite growing evidence that infection-induced mortality is very often a by-product of host immune responses. We extend the theoretical framework of the trade-off hypothesis to incorporate such immunopathology and explore how this detrimental aspect of host defence mechanisms affects the evolution of pathogen exploitation and hence infection-induced mortality. We argue that there are qualitatively different ways in which immunopathology can arise and suggest ways in which empirical studies can tease apart these effects. We show that immunopathology can cause infection-induced mortality to increase or decrease as a result of pathogen evolution, depending on how it covaries with pathogen exploitation strategies and with parasite killing by hosts. Immunopathology is thus an important determinant of whether public and animal health programmes will drive evolution in a clinically beneficial or detrimental direction. Immunopathology complicates our understanding of disease evolution, but can nevertheless be readily accounted for within the framework of the trade-off hypothesis.
Day
Troy
T
Department of Mathematics and Statistics, Jeffery Hall, Queen's University, Kingston, Canada K7L 3N6. tday@mast.queensu.ca
Graham
Andrea L
AL
Read
Andrew F
AF
D000818:Animals; D001419:Bacteria; D005075:Biological Evolution; D006790:Host-Parasite Interactions / Q000502:physiology*; D008954:Models, Biological; D010271:Parasites / Q000235:genetics / Q000472:pathogenicity*; D012641:Selection, Genetic; D014774:Virulence; D037521:Virulence Factors / Q000235:genetics; D014780:Viruses
D037521:Virulence Factors
Proc Biol Sci. 1999 May 22;266(1423):1069-75
10380683
Virology. 2000 Aug 15;274(1):94-104
10936092
Eur J Immunol. 2001 Sep;31(9):2566-73
11536154
Nature. 2001 Dec 13;414(6865):751-6
11742400
Evolution. 2001 Dec;55(12):2389-400
11831655
Proc Biol Sci. 2002 Jul 7;269(1498):1317-23
12079653
Adv Parasitol. 2002;52:265-307
12521263
Trends Microbiol. 2003 Jan;11(1):15-20
12526850
Proc Biol Sci. 2003 Feb 7;270(1512):289-98
12614579
Parasitology. 2003 Feb;126(Pt 2):103-12
12636347
Evolution. 2003 Mar;57(3):671-6
12703956
Science. 2003 Jul 25;301(5632):472-5
12881560
Infect Immun. 2003 Sep;71(9):4850-6
12933825
Clin Exp Immunol. 1992 Jun;88(3):499-505
1351432
Int J Parasitol. 1992 Nov;22(7):861-907
1459783
J Immunol. 2004 Jul 15;173(2):721-5
15240656
Clin Microbiol Rev. 2004 Jul;17(3):509-39, table of contents
15258091
Am Nat. 2005 Jun;165(6):E155-67
15937740
Nat Rev Immunol. 2005 Sep;5(9):722-35
16138104
Parasite Immunol. 2006 Jan-Feb;28(1-2):35-49
16438675
Lancet Infect Dis. 2006 Apr;6(4):242-8
16554249
Nat Med. 2006 Oct;12(10):1203-7
16964257
Parasitology. 2006 Dec;133(Pt 6):673-84
16978451
Immunol Cell Biol. 2007 Jan;85(1):33-42
17146465
Immunol Cell Biol. 2007 Feb-Mar;85(2):93-102
17228320
Nature. 2007 Jan 18;445(7125):319-23
17230189
Annu Rev Pathol. 2006;1:467-96
18039123
Vaccine. 2008 Jul 18;26 Suppl 3:C42-52
18773536
Parasitology. 1982 Oct;85 (Pt 2):411-26
6755367
J Gen Virol. 1995 Feb;76 ( Pt 2):381-91
7531218
J Virol. 1995 Apr;69(4):2187-93
7533851
Q Rev Biol. 1996 Mar;71(1):37-78
8919665
Trends Microbiol. 1997 Jan;5(1):31-7
9025233
J Infect Dis. 1997 May;175(5):1276-80
9129104
Proc Biol Sci. 1998 Feb 22;265(1393):317-25
9523434